Insulin resistance (IR), defined as an attenuated biological response to circulating insulin, is
a fundamental defect in obesity and type 2 diabetes (T2D), and is also linked to a wide …

Background The prevalence of non-alcoholic fatty liver disease (NAFLD) has been
increasing rapidly. It is nowadays recognized as the most frequent liver disease, affecting a …

This update of evidence-based guidelines (GL) aims to translate current evidence and
expert opinion into recommendations for multidisciplinary teams responsible for the optimal …

Due to the rising prevalence of obesity and type II diabetes mellitus, non‐alcoholic fatty liver
disease is becoming the leading cause of chronic liver disease in the Western world. In …

Non-alcoholic fatty liver disease (NAFLD) is a major global health threat due to its growing
incidence and prevalence. It is becoming the leading cause of liver disease in addition to its …

Nonalcoholic fatty liver disease (NAFLD) is rapidly becoming the most common cause of
chronic liver disease due to an increase in the prevalence of obesity. The development of …

Nonalcoholic fatty liver disease (NAFLD) is emerging as the most common chronic liver
disease, and is characterized by a wide spectrum of fat-liver disorders that can result in …

Abstract Background & Aims Malnutrition with the accumulation of fat tissue and
nonalcoholic fatty liver disease (NAFLD) are conditions associated with inflammatory bowel …

Nonalcoholic fatty liver disease (NALFD) is now a leading cause of chronic liver disease
worldwide, in part, as a consequence of rapidly rising levels of obesity and metabolic …

The epidemic of obesity has resulted in a parallel incremental burden of nonalcoholic fatty
liver disease (NAFLD) worldwide. Nonalcoholic fatty liver disease includes a spectrum of …